Vaccine Adjuvants Market By Product Type (Pathogen, Adjuvant Emulsion, And Others), By Route Of Administration (Oral, Intradermal, Subcutaneous), By Disease Type, By Application (Research And Commercial), and Region - Global Forecast to 2023

The global vaccine adjuvants market is expected to value at approximately US$ 0.5 Bn in 2019, and is expected to register a CAGR of 10.4%. The report offers in-depth insights, revenue details, and other vital information regarding the global vaccine adjuvants market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The global vaccine adjuvants market is segmented on the basis of product type, route of administration, disease type, application, and region.

Request Covid - 19 Impact

Global Vaccine Adjuvants Market: Introduction

Vaccine adjuvants help the body to build a strong immune response to protect the person from disease. Adjuvants are added to vaccines to work better by improving response of the body to vaccination and reduces the number of vaccine doses given to patients.

Global Vaccine Adjuvants Market: Dynamics

Major factors driving growth of the global vaccine adjuvants market are increasing technological advancements focusing on improved and long-lasting vaccines for existing and emerging chronic diseases and growing government expenditure on research and development of adjuvant vaccines. Additionally, R&D enables evaluating adjuvant safety and efficacy for improving and standardizing animal models, and correlating different immune responses with individual characteristics such as age, gender, ethnicity, genetics, underlying chronic illness etc.

Increasing demand for vaccine adjuvants for preventing various high predominant chronic diseases such as arthritis, cancer, diabetes, epilepsy, obesity, allergy etc. is projected to drive growth of the target market. Vaccines are among some of the most effective medical inventions against various infectious diseases, and sometimes require a molecule in conjugation that enhances its immune response.

However, less safety pertaining to vaccine adjuvants is expected to hamper growth of the global target market to certain extent. Adjuvants act as immune-stimulants and may induce unwanted immune processes that could trigger the arrival of immune-mediated disease in vulnerable individuals.

Development of new vaccine adjuvants required for pandemic diseases like influenza, is a factor expected to create a lucrative opportunity for driving growth of the target market in the next coming years.

Global Vaccine Adjuvants Market Analysis, by Product Type

On the basis of product type segmentation, the particulate segment is expected to contribute major revenue share and is projected to maintain its dominance over the forecast period. This dominance is attributed to the increasing adoption for pathogen adjuvants for treatment of various diseases such as hepatitis B, human papillomavirus coupled with increasing prevalence of these diseases across the globe.

Global Vaccine Adjuvants Market Analysis, by Route of Administration

On the basis of route of administration segmentation, intramuscular segment is expected to contribute major revenue share of the market and is expected to maintain its dominance over the forecast period. The intramuscular segment is projected to register significant CAGR over 10.2%, over the forecast period, owing to increasing demand for intramuscular vaccine adjuvants to treat various diseases such as influenza, human papillomavirus (HPV), coupled with increasing prevalence of these diseases.

Global Vaccine Adjuvants Market Analysis, by Disease Type

On the basis of disease type segmentation, the infectious disease segment is expected to contribute major revenue share of the market and is expected to maintain its dominance over the forecast period. The infectious disease segment is projected to register significant CAGR over 10.1%, over the forecast period. Growing prevalence of infectious diseases such as malaria, influenza, hepatitis A, B, & C, and others in developed and developing countries is expected to support revenue growth of the segment.

Global Vaccine Adjuvants Market Analysis, by Application

On the basis of application segmentation, the research segment is expected to contribute major revenue share of the market and is expected to maintain its dominance over the forecast period. The research segment is projected to register significant CAGR over 10%, over the forecast period, owing to various research institutes and government organizations for R&D of adjuvant and vaccines.

Global Vaccine Adjuvants Market Analysis, by Region:

The market in North America accounted for major revenue share in the global vaccine adjuvants market in 2018 and is projected to maintain its dominance over the forecast period. The North America vaccine adjuvants market is expected to register a significant CAGR during the forecast period. Demand for vaccine adjuvants has been increasing significantly due to presence of advanced medical facilities and developed healthcare infrastructure, coupled with high adoption of technologically advanced healthcare products and devices in countries in the region. In addition, increasing government initiatives for spreading awareness about various infectious diseases and cancers, coupled with favorable reimbursement policies, is another factor expected to drive revenue growth of the market in the region.

The Asia Pacific market is projected to register highest CAGR of over 10.6% in the global vaccine adjuvants market during the forecast period. This can be attributed to increasing incidence of various infectious diseases, presence of large patient pool, and increasing government initiatives for spreading awareness about treatment of various diseases, especially in emerging economies such as China and India. Furthermore, increasing geriatric population and increasing incidence of obesity and diabetes, which could lead to severe health problems including cancer, are among other factors expected to propel the need for developed and well-equipped medical care facilities, which in turn is projected to fuel growth of the Asia Pacific vaccine adjuvants market over the forecast period

The market in Middle East & Africa accounted for considerable revenue share in the global vaccine adjuvants market and is projected to register a CAGR over 9% over the forecast period.

Global Vaccine Adjuvants Market segmentation:

Segmentation on The Basis of Product Type:

• Pathogen
• Adjuvant Emulsion
• Particulate
• Combination
• Others

Segmentation on The Basis of Route of Administration:

• Oral
• Intradermal
• Intranasal
• Intramuscular
• Subcutaneous

Segmentation on The Basis of Disease Type:

• Infectious Disease
• Cancer

Segmentation on The Basis of Application:

• Research
• Commercial

Segmentation on the Basis of Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Brenntag Biosector A/S
• CSL Limited
• Air Liquide S.A.
• Agenus Inc.
• Novavax, Inc.
• Associated British Foods plc (SPI Pharma, Inc.)
• InvivoGen Inc.
• Avanti Polar Lipids, Inc.
• MVP Laboratories Inc.
• OZ Biosciences